Third time’s the charm: Dynavax shares rocket 18% on hepatitis B vaccine approval
November 10, 2017 at 08:47 AM EST
The vaccine is then first new hepatitis B one in the U.S. in decades and should be a lot more convenient to get.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|